Table 5_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

Table 1_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

Table 4_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

Table 3_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

Table 6_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

Table 2_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

Frontier analysis findings: (A) A frontier analysis diagram based on Age-Standardized DALYs Rate (ASDR) and the SDI from 1990 to 2021. حسب Guanghui Yu (423945)

Correlation analysis of red blood cell-platelet ratio and coagulation indicators. حسب Jie Zhao (49409)

الموضوعات:

Univariate analysis of hospitalized patients. حسب Jie Zhao (49409)

الموضوعات:

The red blood cell-platelet ratio affects prognosis. حسب Jie Zhao (49409)

الموضوعات:

Red blood cell-platelet ratio and HR-restriction cube diagram during hospitalization. حسب Jie Zhao (49409)

الموضوعات:

Prognostic model for the red blood cell-platelet ratio and its trajectory categories during hospitalization. حسب Jie Zhao (49409)

الموضوعات:

Prognostic Impact of Red Blood Cell-Platelet Ratio Trajectory Categories after PSM. حسب Jie Zhao (49409)

الموضوعات:

Clinical baseline data. حسب Jie Zhao (49409)

الموضوعات:

Univariate analysis of ICU patients. حسب Jie Zhao (49409)

الموضوعات:

Prognostic model for the red blood cell-platelet ratio and its trajectory categories during ICU stay. حسب Jie Zhao (49409)

الموضوعات:

Impact of red blood cell-platelet ratio trajectories in the first four days before ICU admission on prognosis and clinical outcomes in the validation set. حسب Jie Zhao (49409)

الموضوعات:

Clinical baseline data after PSM. حسب Jie Zhao (49409)

الموضوعات:

Impact of red blood cell-platelet ratio trajectories on prognosis and clinical outcomes in the first four days before ICU admission in the training set. حسب Jie Zhao (49409)

الموضوعات:

International Classification of Diseases Codes. حسب Jie Zhao (49409)

الموضوعات: